Trelegy Ellipta®) and budesonide/glycopyrronium/formoterol fumarate (Breztri Aerosphere®) for moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)Collaborative Prescribing Agreement • November 7th, 2022
This Collaborative Prescribing Agreement (the "Agreement") is entered into by the Pharmaceutical Services Division, BC Ministry of Health, and the undersigned respirologist.
Collaborative Prescribing AgreementCollaborative Prescribing Agreement • January 8th, 2014
This COLLABORATIVE PRESCRIBING AGREEMENT (the CPA or "Agreement") is entered into by the Medical Beneficiary and Pharmaceutical Services Division, Ministry of Health, B.C., and the undersigned orthopaedic surgeon.
ContractCollaborative Prescribing Agreement • April 10th, 2017
KBN & KBML Approved Collaborative Agreement for Advanced Practice Registered Nurse Prescriptive Authority for Non-Scheduled Drugs (CAPA-NS)
Collaborative Prescribing AgreementCollaborative Prescribing Agreement • November 25th, 2019
For the prevention of acute and delayed nausea and vomiting due to highly-emetogenic cancer chemotherapy in combination with dexamethasone, for up to a maximum number of standard, planned treatment cycles of
Collaborative Prescribing AgreementCollaborative Prescribing Agreement • July 11th, 2016
This COLLABORATIVE PRESCRIBING AGREEMENT (the "Agreement") is entered into by the Medical Beneficiary and Pharmaceutical Services Division (MBPSD), Ministry of Health, B.C., and the undersigned orthopedic surgeon.
ContractCollaborative Prescribing Agreement • November 17th, 2010
Collaborative Prescribing Agreement BUPRENORPHINE PLUS NALOXONE for SubstitutionTreatment of Opioid Dependence in Adults This COLLABORATIVE PRESCRIBING AGREEMENT (the "Agreement") is entered into by the Pharmaceutical Services Division (PSD), Ministry of Health Services, B.C., and the undersigned methadone maintenance prescriber. To obtain PharmaCare coverage on my patients’ behalf for buprenorphine plus naloxone (Suboxone®), I, , a methadone maintenance prescriber,Name of physician (please print)agree to prescribe according to the following Limited Coverage criteria: Treatment of opioid dependence where methadone is contraindicated (e.g., for patients at high risk of, or with QTc prolongation or those with a hypersensitivity to methadone) OR where there is an inadequate response or intolerance to methadone.Patients being considered for buprenorphine plus naloxone are at low risk for drug diversion. Notes: 1. The College of Physicians and Surgeons of British Columbia limits the prescri
Collaborative Prescribing AgreementCollaborative Prescribing Agreement • July 14th, 2017
This Collaborative Prescribing Agreement (the "Agreement") is entered into by the Pharmaceutical Services Division, BC Ministry of Health, and the undersigned prescriber.
Collaborative Prescribing AgreementCollaborative Prescribing Agreement • June 17th, 2011
This COLLABORATIVE PRESCRIBING AGREEMENT (the "Agreement") is entered into by the Pharmaceutical Services Division (PSD), Ministry of Health, B.C., and the undersigned prescriber.
Kentucky Board of Nursing and Kentucky Board of Medical Licensure Approved Collaborative Agreement for Advanced Practice Registered NurseCollaborative Prescribing Agreement • July 10th, 2015
WHEREAS, this Collaborative Prescribing Agreement is entered by and between the APRN and the Physician for the sole purpose of defining the scope of prescriptive authority to be exercised by the APRN, all in compliance with the applicable sections of KRS Chapter 314; and
ContractCollaborative Prescribing Agreement • August 9th, 2017
Common Collaborative Agreement for Advanced Practice Registered Nurse Prescriptive Authority for Non-Scheduled Drugs (CAPA-NS) Form
